Skip to content

Defilade Capital Management, L.P.

Follow

13F filer, CIK 2088557, EMERYVILLE, CA

Defilade Capital Management, L.P. reported $598,799,890 across 30 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 54.91% of the portfolio.

Accepted , ingested 13F-HR 0002088557-26-000010

Period
2026-09-30
Reported value
$599M
Holdings
30
Top 10 weight
54.91%
New
8
Sold out
17

Largest buys vs the previous quarter

SecurityShares changeApprox. value
GILDnew+226,572$33.8M
AXSMnew+175,371$32.3M
AMGNnew+74,079$31.2M
ISRGnew+71,860$29.2M
SYKnew+81,524$22.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VEEVreduced-167,568-$47.8M
PTCTexited-433,699-$35.4M
BAXexited-1,459,380-$31.1M
INSMexited-281,838-$30M
ZBHexited-317,426-$27.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0002088557-26-000010, largest first. % of portfolio is the value over $598,799,890, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
PFEPFIZER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 2,203,504 shares; 2026Q1: 1,464,129 shares; 2026Q2: 1,771,743 shares; 2026Q3: 1,524,999 shares 1,524,999$43.5M7.26%-246,744Timeline
LLYELI LILLY & COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 31,950 shares; 2026Q1: 20,696 shares; 2026Q2: 39,086 shares; 2026Q3: 34,774 shares 34,774$40.2M6.72%-4,312Timeline
BMRNBIOMARIN PHARMACEUTICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 682,005 shares; 2026Q3: 601,922 shares 601,922$36.1M6.03%-80,083Timeline
GILDGILEAD SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 226,572 shares 226,572$33.8M5.64%newTimeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 175,371 shares 175,371$32.3M5.4%newTimeline
AMGNAMGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 74,079 shares 74,079$31.2M5.21%newTimeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 842,928 shares; 2026Q2: 1,047,690 shares; 2026Q3: 2,272,497 shares 2,272,497$30.6M5.11%+1,224,807Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 94,843 shares; 2026Q3: 128,858 shares 128,858$29.4M4.9%+34,015Timeline
ISRGINTUITIVE SURGICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 45,662 shares; 2026Q1: 67,681 shares; 2026Q2: not reported; 2026Q3: 71,860 shares 71,860$29.2M4.88%newTimeline
SYKSTRYKER CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 81,524 shares 81,524$22.5M3.75%newTimeline
VERAVERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 652,377 shares 652,377$21.1M3.52%newTimeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 568,619 shares; 2026Q1: 352,590 shares; 2026Q2: 393,441 shares; 2026Q3: 631,645 shares 631,645$20.2M3.38%+238,204Timeline
VEEVVEEVA SYS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 236,709 shares; 2026Q3: 69,141 shares 69,141$19.7M3.3%-167,568Timeline
RPRXROYALTY PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 332,200 shares 332,200$19.4M3.24%newTimeline
AGIOAGIOS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 546,848 shares; 2026Q3: 570,318 shares 570,318$19M3.17%+23,470Timeline
TMOTHERMO FISHER SCIENTIFIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 51,934 shares; 2026Q3: 26,469 shares 26,469$17.9M2.98%-25,465Timeline
OCULOCULAR THERAPEUTIX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 681,663 shares; 2026Q1: 1,487,645 shares; 2026Q2: 1,490,286 shares; 2026Q3: 2,275,512 shares 2,275,512$17.5M2.91%+785,226Timeline
LRMRLARIMAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,670,135 shares; 2026Q3: 4,934,439 shares 4,934,439$15.8M2.63%+1,264,304Timeline
BSXBOSTON SCIENTIFIC CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 350,778 shares 350,778$15.3M2.56%newTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 363,454 shares; 2026Q1: 315,972 shares; 2026Q2: 82,827 shares; 2026Q3: 71,186 shares 71,186$14.6M2.44%-11,641Timeline
SOLVSOLVENTUM CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 316,454 shares; 2026Q3: 165,673 shares 165,673$14.6M2.44%-150,781Timeline
NVSTENVISTA HOLDINGS CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 726,108 shares; 2026Q3: 534,430 shares 534,430$12.5M2.09%-191,678Timeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,234,634 shares; 2026Q1: 1,504,536 shares; 2026Q2: 924,758 shares; 2026Q3: 1,440,157 shares 1,440,157$12.4M2.08%+515,399Timeline
EVMNEVOMMUNE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 215,418 shares; 2026Q1: 678,589 shares; 2026Q2: 793,145 shares; 2026Q3: 1,430,573 shares 1,430,573$11.8M1.97%+637,428Timeline
ELDNELEDON PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 3,290,450 shares; 2026Q1: 3,564,127 shares; 2026Q2: 3,525,338 shares; 2026Q3: 3,525,338 shares 3,525,338$8.92M1.49%0Timeline
ICUIICU MED INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 340,745 shares; 2026Q1: 254,291 shares; 2026Q2: 105,700 shares; 2026Q3: 54,435 shares 54,435$8.74M1.46%-51,265Timeline
ENOVENOVIS CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 531,945 shares; 2026Q3: 399,651 shares 399,651$7.3M1.22%-132,294Timeline
PACSPACS GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,145,485 shares; 2026Q1: 604,180 shares; 2026Q2: 215,675 shares; 2026Q3: 164,984 shares 164,984$6.86M1.14%-50,691Timeline
BDTXBLACK DIAMOND THERAPEUTICS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,674,999 shares; 2026Q3: 1,770,948 shares 1,770,948$3.34M0.56%+95,949Timeline
MREOMEREO BIOPHARMA GROUP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 7,558,756 shares; 2026Q2: 7,558,756 shares; 2026Q3: 7,558,756 shares 7,558,756$3.04M0.51%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
PTCTPTC THERAPEUTICS INC433,699$35.4Mshares
BAXBAXTER INTL INC1,459,380$31.1Mshares
INSMINSMED INC281,838$30Mshares
ZBHZIMMER BIOMET HOLDINGS INC317,426$27.3Mshares
PODDINSULET CORP176,932$26.9Mshares
ABTABBOTT LABORATORIES285,778$25.9Mshares
MDTMEDTRONIC PLC303,301$23.7Mshares
ELANELANCO ANIMAL HEALTH INC864,080$21.3Mshares
LNTHLANTHEUS HLDGS INC132,662$14.7Mshares
TYRATYRA BIOSCIENCES INC376,870$12Mshares
GMEDGLOBUS MED INC139,637$11Mshares
TFXTELEFLEX INCORPORATED80,118$10.2Mshares
DNLIDENALI THERAPEUTICS INC391,866$10.1Mshares
GKOSGLAUKOS CORP66,519$9.3Mshares
STAASTAAR SURGICAL CO322,126$9.24Mshares
CRNXCRINETICS PHARMACEUTICALS IN239,440$8.96Mshares
LIVNLIVANOVA PLC107,373$8.83Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0002088557-26-000010 base2026-11-16